Bellerophon Therapeutics (NASDAQ:BLPH) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research report report published on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Stock Down 1.1 % Shares of BLPH stock opened at $0.06 on Thursday. Bellerophon Therapeutics has a 12 month low of […]

Related Keywords

United States , ,Dimensional Fund Advisors ,Bellerophon Therapeutics Inc ,Renaissance Technologies ,Geode Capital Management ,Bellerophon Therapeutics ,Free Report ,Therapeutics Stock Down ,Street Corp ,Fund Advisors ,Capital Management ,Get Free Report ,Bellerophon Therapeutics Daily ,Nasdaq Blph ,Blph ,Medical ,Initiated Coverage ,Stocknews Com ,